Richard King

The Scripps Research Institute has appointed Richard King as chief operating officer. King was the former president and CEO of AcelRx Pharmaceuticals. Prior to AcelRx, he held positions as president and general manager of Tercica and as executive vice president of commercial operations at Kos Pharmaceuticals.